Pharma M&A Passed $200B In 2014, Primed For More In 2015
This article was originally published in The Tan Sheet
Executive Summary
The pharma industry in 2014 products its biggest M&A year in recent history, though it may be remembered equally for sagas and upsets that failed to materialize into finalized deals. Actavis was the most aggressive acquirer, buying Forest and Allergan for a total of $89.3 billion in the two most expensive deals of the year.